Close

Lexicon Pharma (LXRX) Tops Q2 EPS by 5c

August 7, 2015 7:30 AM EDT

Lexicon Pharma (NASDAQ: LXRX) reported Q2 EPS of ($0.27), $0.05 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $376 million versus the consensus estimate of $360 thousand.

For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings